{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T04:26:06Z","timestamp":1773807966552,"version":"3.50.1"},"reference-count":10,"publisher":"Elsevier BV","issue":"5-6","license":[{"start":{"date-parts":[[2003,6,1]],"date-time":"2003-06-01T00:00:00Z","timestamp":1054425600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neural Networks"],"published-print":{"date-parts":[[2003,6]]},"DOI":"10.1016\/s0893-6080(03)00084-4","type":"journal-article","created":{"date-parts":[[2003,6,21]],"date-time":"2003-06-21T08:37:35Z","timestamp":1056184655000},"page":"841-845","source":"Crossref","is-referenced-by-count":41,"title":["Pharmacodynamic population analysis in chronic renal failure using artificial neural networks\u2014a comparative study"],"prefix":"10.1016","volume":"16","author":[{"given":"Adam E.","family":"Gaweda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfred A.","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael E.","family":"Brier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacek M.","family":"Zurada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S0893-6080(03)00084-4_BIB1","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1006\/cbmr.1993.1019","article-title":"Drug delivery optimization through Bayesian networks: an application to erythropoietin therapy in uremic anemia","volume":"26","author":"Bellazzi","year":"1992","journal-title":"Computers and Biomedical Research"},{"key":"10.1016\/S0893-6080(03)00084-4_BIB2","first-page":"154","article-title":"Mathematical modeling of erythropoietin therapy in uremic anemia. Does it improve cost-effectiveness?","volume":"79","author":"Bellazzi","year":"1994","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/S0893-6080(03)00084-4_BIB5","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1023\/A:1016260720218","article-title":"Neural network predicted peak and trough gentamicin concentrations","volume":"12","author":"Brier","year":"1995","journal-title":"Pharmaceutical Research"},{"issue":"1","key":"10.1016\/S0893-6080(03)00084-4_BIB8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/153537020322800101","article-title":"Erythropoietin: physiology and pharmacology update","volume":"228","author":"Fisher","year":"2003","journal-title":"Experimental Biology and Medicine"},{"key":"10.1016\/S0893-6080(03)00084-4_BIB7","article-title":"Use of neural networks for dosage individualisation of erythropoietin in patients with secondary anemia to chronic renal failure","author":"Guerrero","year":"2003","journal-title":"Computers in Biology and Medicine"},{"key":"10.1016\/S0893-6080(03)00084-4_BIB6","first-page":"p. 387A","article-title":"Predictors of hematocrit in hemodialysis patients as determined by artificial neural networks","volume":"12","author":"Jacobs","year":"2001","journal-title":"Journal of American Society of Nephrology"},{"key":"10.1016\/S0893-6080(03)00084-4_BIB9","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1109\/72.182710","article-title":"Functional equivalence between radial basis function and fuzzy inference systems","volume":"4","author":"Jang","year":"1993","journal-title":"IEEE Transactions on Neural Networks"},{"issue":"2","key":"10.1016\/S0893-6080(03)00084-4_BIB10","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/int.4550100206","article-title":"Optimal fuzzy rules cover extrema","volume":"10","author":"Kosko","year":"1995","journal-title":"International Journal of Intelligent Systems"},{"issue":"4","key":"10.1016\/S0893-6080(03)00084-4_BIB3","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/BF01062465","article-title":"Neural networks in pharmacodynamic modeling. Is current modeling practice of complex kinetic systems at a dead end?","volume":"20","author":"Veng-Pedersen","year":"1992","journal-title":"Journal of Pharmacokinetics and Biophamraceutics"},{"key":"10.1016\/S0893-6080(03)00084-4_BIB4","first-page":"101","article-title":"Application of neural networks in pharmacodynamics","volume":"2","author":"Veng-Pedersen","year":"1995"}],"container-title":["Neural Networks"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893608003000844?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893608003000844?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,19]],"date-time":"2019-03-19T11:22:31Z","timestamp":1552994551000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893608003000844"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,6]]},"references-count":10,"journal-issue":{"issue":"5-6","published-print":{"date-parts":[[2003,6]]}},"alternative-id":["S0893608003000844"],"URL":"https:\/\/doi.org\/10.1016\/s0893-6080(03)00084-4","relation":{},"ISSN":["0893-6080"],"issn-type":[{"value":"0893-6080","type":"print"}],"subject":[],"published":{"date-parts":[[2003,6]]}}}